Structural basis for olivetolic acid formation by a polyketide cyclase from Cannabis sativa by Yang Xinmei et al.
 1 
Structural basis for olivetolic acid formation by a polyketide 
cyclase from Cannabis sativa 
 
Xinmei Yang1, Takashi Matsui1, Takeshi Kodama1, Takahiro Mori2, Xiaoxi Zhou1, Futoshi 
Taura3, Hiroshi Noguchi4, Ikuro Abe2* & Hiroyuki Morita1* 
 
1 Institute of Natural Medicine, University of Toyama, 2630-Sugitani, Toyama 930-0194, Japan. 
2 Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 
Tokyo 113-0033, Japan. 
3 Graduate School of Medicine and Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical 
Sciences, University of Toyama, 2630-Sugitani, Toyama 930-0194, Japan. 
4 School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga, Shizuoka 422-8526, 
Japan. 
Address correspondence to Hiroyuki Morita (Institute of Natural Medicine, University of Toyama, 
2630-Sugitani, Toyama 930-0194, Japan. TEL: +81-76-434-7625; FAX: +81-76-434-5059, E-mail: 
hmorita@inm.u-toyama.ac.jp), or Ikuro Abe (Graduate School of Pharmaceutical Sciences, The 
University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. TEL: +81-3-5841-4740; FAX: 
+81-3-5841-4744, E-mail: abei@mol.f.u-tokyo.ac.jp). 
Running title: Crystal structure of olivetolic acid cyclase 
Abbreviations: ACP, acyl carrier protein; AtHS1, Arabidopsis thaliana heat stable protein; Betv1, 
Betula verrucosa birch pollen allergen; DABB, dimeric a+b barrel; GST, Glutathione S-transferase; 
IPTG, isopropyl-b-D-thiogalactopyranoside; MLMI, 4-methylmuconolactone methylisomerase; NAC, 
N-Acetylcysteamine; NTF-2, nuclear transport factor 2; OA, olivetolic acid; OAC, olivetolic acid 
cyclase; PF, Photon Factory; PKS, polyketide synthase; SAD, single-wavelength anomalous 
diffraction; Se-Met, selenomethionine; SP1, Populus tremula boiling stable protein; Tcm ARO/CYC, 
tetracenomycin aromatase/cyclase; TcmI, tetracenomycin F2 cyclase; TKS, tetraketide synthase. 
Enzyme EC numbers: Olivetolic acid cyclase, EC 4.4.1.26; tetraketide synthase, EC 2.3.1.206. 
Data deposition: Structural data reported in this paper are available in the Protein Data Bank under 
the accession numbers 5B08 for the OAC apo, 5B09 for the OAC-OA binary complex, and 5B0A, 
5B0B, 5B0C, 5B0D, 5B0E, 5B0F, and 5B0G for the OAC His5Q, Ile7F, Tyr27F, Tyr27W, Val59M, 
 2 
Tyr72F, and His78S mutant enzymes, respectively. 
Keywords: crystal structure, enzyme mechanism, olivetolic acid cyclase, Cannabis sativa, DABB 
protein 
Conflict of interest: The authors declare that they have no conflicts of interest. 
 3 
Abstract 
In polyketide biosynthesis, ring formation is one of the key diversification steps. Olivetolic acid 
cyclase (OAC) from Cannabis sativa, involved in cannabinoid biosynthesis, is the only known plant 
polyketide cyclase. In addition, it is the only functionally characterized plant a+b barrel (DABB) 
protein that catalyzes the C2-C7 aldol cyclization of the linear pentyl tetra-b-ketide CoA as the 
substrate, to generate olivetolic acid (OA). Herein, we solved the OAC apo and OAC-OA complex 
binary crystal structures at 1.32 and 1.70 Å resolutions, respectively. The crystal structures revealed 
that the enzyme indeed belongs to the DABB superfamily, as previously proposed, and possesses a 
unique active-site cavity containing the pentyl-binding hydrophobic pocket and the polyketide binding 
site, which have never been observed among the functionally and structurally characterized bacterial 
polyketide cyclases. Furthermore, site-directed mutagenesis studies indicated that Tyr72 and His78 
function as acid/base catalysts at the catalytic center. Structural and/or functional studies of OAC 
suggested that the enzyme lacks thioesterase and aromatase activities. These observations 
demonstrated that OAC employs unique catalytic machinery utilizing the acid/base catalytic chemistry 
for the formation of the precursor of OA. The structural and functional insights obtained this work thus 
provide the foundation for analyses of the plant polyketide cyclases that will be discovered in the 
future. 
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Introduction 
Polyketide cyclases, such as Streptomyces nogalater SnoaL [1, 2] (Fig. 1A), S. glaucescens 
tetracenomycin aromatase/cyclase (Tcm ARO/CYC) [3, 4] (Fig. 1B), and S. glaucescens 
tetracenomycin (Tcm) F2 cyclase (TcmI) [5, 6] (Fig. 1C), are key enzymes that diversify the structures 
of pharmaceutically and biologically important natural polyketides. The enzymes catalyze aldol 
cyclization(s) to generate new cyclic or aromatic ring system(s) of the polyketides, such as 
nogalamycin [1] and Tcm C [3, 5]. The polyketide cyclases are structurally divided into three types, 
nuclear transport factor (NTF2)-like polyketide cyclase, Betula verrucosa birch pollen allergen 
(Betv1)-like polyketide cyclase, and dimeric a+b barrel (DABB)-type polyketide cyclase. The crystal 
structures of the NTF2-like polyketide cyclase SnoaL, involved in nogalamycin biosynthesis, and the 
Betv1-like polyketide cyclase Tcm ARO/CYC, involved in Tcm C biosynthesis, revealed the detailed 
enzyme reaction mechanisms, as well as the active-site architectures [2, 4]. Further structure-based 
mutagenesis studies suggested that SnoaL utilizes the single catalytic residue Asp121 as the acid/base 
catalyst for the C10-C9 aldol cyclization of nogalonic acid methyl ester as the substrate, to generate 
nogalaviketone. In contrast, TcmARO/CYC utilizes the catalytic triad Tyr35-Arg69-Arg82 and a water 
molecule as the acid/base catalysts for the C14-C9 and C16-C7 aldol cyclizations and aromatization of 
the acyl carrier protein (ACP)-tethered acetyl-b-decaketide as the substrate, to generate the precursor 
of ACP-tethered Tcm F2. The crystal structure of the DABB-type polyketide cyclase TcmI, involved in 
the biosynthesis of Tcm C, has also been characterized. However, the detailed mechanism of the C9-
C10 aldol cyclization of Tcm F2, for the formation of Tcm F1, has remained elusive [6]. 
The recently identified olivetolic acid cyclase (OAC) from Cannabis sativa is the only 
known plant polyketide cyclase that has been proposed to be involved in the biosynthesis of 
cannabinoid [7]. The in vitro functional analysis, using the recombinant OAC and the recombinant C. 
sativa type-III polyketide synthase (PKS), tetraketide synthase (TKS), suggested that OAC accepts a 
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linear pentyl tetra-b-ketide CoA as the substrate, without interacting with TKS in a similar manner to 
chalcone reductase [8], and performs the C2–C7 aldol cyclization, thioester bond cleavage, and 
aromatization reactions to generate olivetolic acid (OA), without requiring any co-factors (Fig. 1D) [7]. 
The enzyme is a homodimeric protein, with each subunit consisting of 101 amino acid residues [7, 9], 
and shares 30–50% identity with the other plant DABB superfamily proteins, such as the structurally 
characterized and functionally uncharacterized heat stable protein (AtHS1) from Arabidopsis thaliana 
[10, 11], boiling stable protein (SP1) from Populus tremula [12], and At5g22580 from A. thaliana [13]. 
In contrast, the enzyme exhibits low identity (less than 20%) with the bacterial DABB proteins (Fig. 2), 
such as TcmI [6], the functionally distinct, structurally characterized ActVA-Orf6 monooxygenase 
from S. coelicolor [14], and 4-methylmuconolactone methylisomerase (MLMI) from Pseudomonas 
reinekei [15]. The structure modeling study of OAC suggested that OAC is a member of the DABB-
type polyketide cyclases and possesses a hydrophobic tunnel as the active-site cavity in each monomer 
[7], as in the cases of the other structurally characterized DABB proteins. Furthermore, site-directed 
mutagenesis studies suggested that three His residues (His5, His57, and His78) play crucial roles in 
the OA-forming activity [7]. Thus, OAC is likely to employ acid/base catalytic chemistry for the 
formation of OA, as proposed for the structurally and functionally distinct SnoaL and Tcm ARO/CYC 
from OAC [2, 4]. However, the catalytic mechanism underlying the substrate and product specificities, 
the aldol cyclization and aromatization reactions, and the thioester bond cleavage, as well as the 
catalytic role of the three His residues in the OA-forming activity, have remained unclear.  
 Herein, we present the crystal structure of OAC, the only known plant polyketide cyclase. 
The OA complex binary crystal structure of OAC clearly revealed the active-site architecture, 
containing a 9 Å long pentyl moiety binding pocket and a putative polyketide binding site. 
Furthermore, site-directed mutagenesis studies allowed us to identify Tyr72/His78 as the catalytic 
residues for the formation of OA. Our crystallographic analysis of OAC provides insight into the 
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structural basis for the catalytic mechanism of this plant polyketide cyclase. 
 
Results 
Overall structure of OAC 
The apo crystal structure of OAC was also solved by the Se-SAD method and refined at 1.32 Å 
resolution. The asymmetric unit contains two monomers, which further form a dimer (Fig. 3A). 
Significant conformational differences between monomers A and B were observed in the residues 65-
88, with root mean square (r. m. s.) deviation values of 1.9 Å for all Ca atoms relative to each other 
(Fig. 3B). The monomer A consists of a four-stranded antiparallel β-sheet and three α-helixes (a1-a3), 
while the monomer B consists of a four-stranded antiparallel β-sheet and two α-helixes (a1’ and η2’). 
The outer surface of the antiparallel β-sheets faces to each other and form a central a+b barrel core. 
Upon dimerization, each monomer buries approximately 1290 Å2 of the surface, corresponding to 
19.5% of the total surface area. 
 In contrast, the OAC and OA binary complex structure was solved by the molecular 
replacement method, and refined at 1.70 Å resolution. The asymmetric unit of the binary complex 
crystal contains a monomer, which further forms a biologically active symmetric dimer with a 
crystallographic two-fold axis (Fig. 3C, D). As in the case of monomer A in the OAC apo structure, the 
monomer of the binary complex consists of a four-stranded antiparallel β-sheet and three α-helixes 
(a1-a3) (Fig. 3A, C). The outer surfaces of the antiparallel β-sheets face each other and form a central 
a+b barrel core. Upon dimerization, each monomer buries approximately 1,420 Å2 of the surface, 
corresponding to 22.3% of the total surface area. Several hydrogen bonds and hydrophobic 
interactions are involved in the dimerization (Fig. 3D). The electron density in the binary complex 
structure of OAC clearly indicated the presence of the OA molecule in the cavity (Fig. 3C, D, E). Thus, 
the binary complex structure indicated that OAC possesses an active-site cavity in the interior of the 
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a+b barrel in each monomer, and the active-site entrance is open at the center of a2, a3, and b4, in a 
location and orientation similar to those of the hydrophobic cavities observed in AtHS1, SP1, and 
At5g22580 [10–13] (Fig. 4A–D).  
 A comparison of the overall structure of OAC apo and the binary complex revealed that the 
structure of OAC-OA binary complex is nearly identical to the structure of monomer A of the apo 
structure, with a root-mean-square r. m. s. deviation value of 0.7 Å (Fig. 3F). There are no significant 
backbone changes between the monomer A and OAC-OA binary complex structures, except for 
residues 47-54 in the β2-β3 loop, in which residues 51-53 are disordered in the binary complex 
structure (Fig. 3F). However, the comparison of the overall structure of the binary complex and 
monomers A and B of the OAC apo indicated that the monomer B shows an artificial structure, due to 
great influence of the crystallographic packing. In particular, the structural conversion of the α2 and α3 
(residues 65-73 and 76-88, respectively) and an α2-α3 loop (residues 74-75) in monomer A into β3-η2’ 
and η2’-β4 loops (residues 65-69 and 74-88, respectively) and a one-turn helix (η2’, residues 70-73) in 
monomer B by the crystallographic packing resulted in the disappearance of the active site cavity from 
monomer B (Fig. 3B). Due to the high structural conservation between monomer A and the binary 
complex structures and the artificial structure of monomer B, further crystal structure analysis of OAC 
was carried out by using the structure of the OAC-OA binary complex. 
 The three-dimensional structure of OAC adopts almost the same overall structure observed 
in the plant and bacterial DABB proteins. A structure-based similarity search revealed that the overall 
structure of the OAC-OA binary complex exhibits r. m. s. deviation values of 1.1 Å, 1.4 Å, and 2.5 Å 
with the plant DABB proteins, AtHS1 (PDB code 1Q4R, 48% identity with OAC) [10, 11], SP1 (PDB 
code 1TR0, 38% identity with OAC) [12], and At5g22580 (PDB code 1RJJ, 32% identity with OAC) 
[13], and of 1.8 Å, 2.2 Å, 2.3Å, 2.4 Å, 2.4, and 2.9 Å with the bacterial DABB proteins, S. nogalater 
SnoaB (PDB code 3KG1, 10% identity with OAC) [16], Mycobacterium tuberculosis Rv0793 (PDB 
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code 1Y0H, 7% identity with OAC) [17], MLMI (PDB code 3HDS, 13% identity with OAC) (15), 
ActVA-Orf6 (PDB code 1N5S, 15% identity with OAC) [14], P. aeruginosa PA3566 (PDB code 
1X7V, 7% identity with OAC) [18], and TcmI (PDB code 1TUW, 17% identity with OAC) [6], 
respectively (Figs. 2 and 4). 
 
Active-site architecture of OAC 
The active-site cavity of OAC is created with His5, Ile7, Leu9, Phe23, Phe24, Tyr27, Val28, Leu30, 
Val40, Val59, Tyr72, Ile73, His78, Phe81, Gly82, Trp89, Leu92, and Ile94 (Fig. 5A). A 9-Å long, 
narrow hydrophobic tunnel, named the pentyl-binding pocket, is located deep inside the active-site 
cavity. The side chains of the previously proposed crucial residues, His5 and His78, create a 
hydrophilic region on the tunnel wall near the entrance, together with the hydroxy groups of Tyr27 and 
Tyr72. The side chains of His5 and His78 also participate in the formation of the active-site entrance, 
together with Ile73, Gly82, Trp89, Leu92, and Ile94. In contrast, Asp96 is located just outside the 
active-site cavity, although the Ala substitution of this residue was previously reported to decrease the 
OA-forming activity [7]. The estimated total volume of the active-site cavity is 270 Å3, which is large 
enough to accommodate the pentyl moiety and part of the tetra-b-ketide moiety of the substrate. The 
OA binding binary structure lacked other large cavities or tunnels, suggesting that the CoA portion of 
the substrate is attached on the protein surface or exposed to the solvent, and does not bind to the 
enzyme. Furthermore, His57, reported as the crucial residue for the OA-forming activity, is located far 
from the pocket and protrudes toward the protein surface (Fig. 3D). Lys4, Lys12, Lys38, Asp45, and 
His75, which exhibited decreased OA-forming activities upon substitutions with Ala [7], are also 
located far from the pocket and protrude toward either the protein surface or the dimerization interface 
(Fig. 3D). These residues are thus proposed to be important for the protein folding or the CoA-binding, 
rather than the catalytic functions. 
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 The crystal structure of the binary complex of OAC and OA clearly indicated that the 
pentyl moiety of the OA molecule is accommodated in the pentyl-binding pocket (Fig. 5A). The 
pentyl-binding pocket is thus filled by the pentyl moiety. In contrast, the dihydroxybenzoate moiety of 
OA is located near the entrance of the active-site cavity. Two hydroxy groups, one of the carboxyl 
oxygens, and part of the aromatic ring of the dihydroxybenzoate moiety are thus exposed to the 
solvent (Fig. 5A). The other carboxyl oxygen forms hydrogen bonds with the side chains of His5 and 
Tyr72, and His5 makes another hydrogen bond with Asp96, in a location outside the active-site cavity. 
Tyr72 makes two more hydrogen bonds with the side chains of Tyr27 and His78, located deep inside 
the active-site cavity and near the active-site entrance, respectively. Notably, the side chain of His78 
protrudes toward the C1 and C6 positions of the aromatic ring of OA, corresponding to the C2 and C7 
positions of the aldol cyclization point on the substrate. The Ne2 atom of the His78 side chain is thus 
located at 3.9 Å and 4.3 Å distances from the C1 and C6 positions, respectively, and is closer than the 
4.8 Å and 5.2 Å distances between the hydroxy group of Tyr72 and the C1 and C6 positions, 
respectively. Furthermore, no metal ions and water molecules were observed in the active-site cavity. 
These observations indicated that the His5/Tyr27/Tyr72/His78/Asp96 arrangement and the pentyl-
binding pocket play crucial roles in controlling the substrate and product specificities of OAC. 
 
Site-directed mutagenesis of OAC and crystal structure analyses of selected OAC mutant 
enzymes 
To further clarify the catalytic mechanism of OAC, we constructed site-directed mutants of the 
hydrophilic and selected key hydrophobic residues lining the active-site cavity, and investigated the 
mechanistic consequences of the point mutations. We also constructed the previously reported His5A 
and His78A mutants [7], to reassess the effects of the mutations. Thus, all mutants were overexpressed 
in E. coli, as GST-fused proteins, and after the GST-tag was removed, the mutant enzymes were used 
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for the enzyme reactions. Among them, the mutant enzymes His5A/D/N, Leu9A/W, Phe23A/I/L/W, 
Phe24A/W, Val28F, Val40F, Val59A/F, and His78A/D, including the His5A and His78A mutants, 
formed inclusion bodies in E. coli. Thus, these mutants were not analyzed in our study. 
 We performed the OAC mutant enzyme and TKS co-incubation assay to assess the effects 
of the mutations, since the linear pentyl tetra-b-ketide-CoA is not available. Thus, the effects of the 
mutations were evaluated on the basis of related activities of the obtained mutant enzymes for the 
formation of OA, as compared with that of wild-type. The HPLC profiles and the related activities are 
summarized in Table 1 and Fig. 6. A co-incubation of the OAC His78S mutant and TKS with 
hexanoyl-CoA and malonyl-CoA as the substrates revealed that OA is no longer produced by the 
mutant enzyme. The LC-MS analysis thus detected only the hexanoyl triacetic acid lactone and pentyl 
triketide pyrone that are produced by TKS from condensation of three and two molecules of malonyl-
CoA with the hexanoyl-CoA, respectively in the reaction mixture. This suggested that, as in the case 
of the previously reported His78A mutant enzyme [7], the His78S mutant completely lost the enzyme 
activity. As in the case of the His78S mutants, the set of the His78N/Q mutants lost the enzyme 
activity. Remarkably, the Tyr72F substitution also abolished the enzyme activity. The crystal structure 
analysis of the His78S mutant enzyme revealed that the His78S substitution only disrupts the 
hydrogen bond between Tyr72 and His78 at the active-site (Fig. 7A, B). The crystal structure of the 
Tyr72F mutant enzyme also indicated that the side chain of Phe72 rotates approximately 17° toward 
the a1 helix, in comparison with that of Tyr72 in the wild-type, thereby disrupting the hydrogen bond 
network between Tyr72 and His78 at the active-site (Fig. 7A, C). However, significant conformational 
changes between the OAC wild-type and Tyr72F mutant enzyme structures were not observed in the 
other active site residues. These results suggested that the hydroxy group of Tyr72 plays an important 
role in elevating the basicity of His78. 
 However, in contrast to the previous report for the His5A mutant enzyme [7], the His5Q, 
 11 
His5S, and His5L substitutions retained the enzyme ability and exhibited 78%, 53%, and 64% 
decreases of the OA-forming activity, respectively. The crystal structure of the His5Q mutant enzyme 
demonstrated that the His5Q substitution did not affect the conformations of any of the active-site 
residues and maintains the hydrogen bonds between His78, Tyr72, and Tyr27 (Fig. 7A, D). 
Remarkably, Gln5 in the mutant enzyme and His5 in the wild-type are superimposable, with nearly 
identical positions in those structures, and retained the hydrogen bond between the side chains of Gln5 
and Asp96. The only significant difference in the mutant enzyme is thus regarded as the acidity of 
Gln5, suggesting that the substitution solely disrupts the approximate contact between His5 and the 
carboxyl group of OA. A comprehensive assessment of the results of the site-directed mutagenesis and 
structural studies suggested that the set of His5S/L substitutions hinders the substrate binding, but does 
not affect the conformations of the other residues. His5 is thus proposed to be more crucial for the 
substrate binding affinity, rather than playing the role of an acid/base catalyst. Presumably, the Asp96A 
substitution in the previous report shifted the location and/or orientation of His5, thereby disrupting 
the approximate contact of His5 with the b-keto moiety of the substrate, and leading to the previously 
reported decrease in the OA-forming activity [7]. 
 Interestingly, despite the lack of a hydroxy group, the Tyr27F substitution displayed a 62% 
increase in the OA-forming activity. In contrast, the Tyr27M, Tyr27W, and Tyr27L substitutions 
showed 70%, 63%, and 52% decreases in the OA-forming activity, respectively. The aromatic ring of 
Tyr27 not only forms the hydrogen bond network with His78 and Tyr72, but also is involved in the 
binding of the pentyl moiety of OA in the OAC-OA binary complex structure. Therefore, the 
substitution may change the size, shape, and hydrophobicity of the active-site cavity, as reflected in the 
observed activities of the mutant enzymes. As expected, the crystal structure of the Tyr27F mutant 
enzyme indicated that the Tyr27F substitution disrupts the hydrogen bond between Tyr27 and Tyr72 
(Fig. 7A, E) observed in the wild-type, but maintains all of the conformations of the active-site 
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residues in the mutant enzyme, in locations and orientations very similar to those in the wild-type. The 
effect of the loss of the hydroxy group of Tyr27 on the hydrogen bond network at the active-site is thus 
regarded to increase both the hydrophobicity of the pentyl-binding pocket and the electrostatic 
interaction between Tyr72 and His78, which enhance the OA-forming activity. Conversely, the crystal 
structure of the Tyr27W mutant enzyme demonstrated that the Tyr27W substitution rearranges the 
hydrogen bond networks with Tyr27, Tyr72, and His78 in the wild-type to those of Trp27, Tyr72, and 
His78, but also results in the protrusion of the Trp27 side chain into the bottom of the pentyl-binding 
pocket, thereby preventing the access of the pentyl moiety of the substrate (Fig. 7A, F). 
 Similar cases of steric constraint were also observed in our site-directed mutagenesis 
studies of the pentyl-binding pocket and the crystal structures of the Ile7F and Val59M mutant 
enzymes. In line with these mutants, the Phe24L, Val59M, Ile7F, and Ile7L substitutions showed 51%, 
35%, 36%, and 15% decreases in the OA-forming activity. The structures of the Ile7F and Val59M 
mutant enzymes indicated that the Ile7F and Val59M substitutions narrow the pentyl-binding pocket 
by constricting the bottom of the cavity, but maintain the hydrogen bonds between His78, Tyr72, and 
Tyr27, and between His5 and Asp96 (Fig. 7A, G, H). The Ile7F, Tyr27W, and Val59M mutant enzymes 
exhibited estimated total cavity volumes of 247 Å3, 204 Å3, and 222 Å3, which are slightly less than 
the 270 Å3 volume of the wild-type OAC. These observations strongly favor the possible catalytic 
roles of Tyr72 and His78 over their roles in the substrate binding affinity, and the crucial roles of His5 
and the pentyl-binding pocket in the binding affinities of the polyketide and the pentyl moiety of the 
substrate, respectively. OAC is thus suggested to employ only acid/base chemistry for the C2-C7 aldol 
cyclization of the substrate, in a similar manner to the structurally and functionally distinct enzymes 
SnoaL and Tcm ARO/CYC [2, 4]. 
 
Thioesterase and aromatase activities of OAC 
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As mentioned above, OAC has also been suggested to catalyze the thioester bond cleavage and 
aromatization reactions to generate OA. However, no residues, metal ions, or water molecules that 
may be involved in the thioester bond cleavage and aromatization were observed in the OAC-OA 
binary complex structure. This suggested that OAC lacks both the thioesterase and aromatase activities. 
To test the thioesterase activity of OAC, we performed an enzyme reaction of OAC using OA 
thioester linked N-acetyl cysteamine (OA-NAC) as the possible assay system, since the linear pentyl 
tetra-b-ketide- and cyclized intermediate-CoAs, -NACs, corresponding acids, and CoA-linked OA 
thioester are not available. NAC and NAC-linked acyl-thioester analogues have been successfully 
utilized as the substrate analogues of the functionally and mechanistically distinct, CoA-SH or CoA 
thioester-requiring other type of enzymes such as the type III polyketide synthases and the CoA 
ligases to investigate their functions, since NAC is the terminal portion of CoA-SH [19-22]. However, 
the LC-MS analysis did not reveal any differences in the production of OA in the reaction mixture of 
OAC with OA-NAC, as compared with that in the control experiments (Fig. 8). The result may be 
account for lacking the hydrolysis activity of OAC, although a possibility of the result derived from 
the structural differences between CoA-linked and NAC-linked OAs is not excluded. Furthermore, a 
docking studies of the OAC substrate, pentyl terta-b-ketide-CoA into the OAC structure suggested that 
His78 may be located near the C2 carbon and C7 carbonyl oxygen of the aldol cyclization point on the 
substrate, and Tyr72 recognizes the side-chain of His78 and thioester carbonyl oxygen of the substrate 
(Fig. 9A). In addition, a docking simulation of the cyclized OAC-intermediate into the OAC structure 
suggested that the side chain of His78 may be located near the carbonyl oxygen of the cyclized 
intermediate, corresponding to that of C7 position of pentyl terta-b-ketide-CoA (Fig. 9B). However, 
the docking models did not show any residues that can activate water molecules or metal ions to 
cleave the thioester bond of the substrate and abstract protons of the cyclic ring on the cyclized 
intermediate. These observations may suggest that OAC lacks the thioesterase and aromatase activities. 
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Discussion 
Our crystal structure and site-directed mutagenesis studies of OAC revealed that OAC possesses the 
unique active-site architecture, as well as catalytic roles of Tyr72 and His78 as acid/base catalysts at 
the catalytic center. Furthermore, structural and/or functional studies of OAC suggested that the 
enzyme lacks thioesterase and aromatase activities. On the basis of these observations, we propose two 
elements for the OAC catalytic mechanism. One is that the catalytic function of OAC is to form the 
CoA-linked cyclized product, corresponding to the precursor of OA. The other is that OAC employs 
the acid/base catalysis chemistry, facilitated by the presence of the proton exchangeable Tyr72 and 
His78, for the formation of the precursor of OA. 
 Thus, after pentyl tetra-b-ketide CoA is loaded into the active-site cavity, (i) OAC 
facilitates a nucleophilic attack by deprotonated His78 activated by Tyr72 to abstract the proton at the 
C2 of the substrate, and produces an enol (or enolate) intermediate (Fig. 10A). Subsequently, (ii) the 
nucleophilic attack of the enol (enolate) intermediate on the C7 carbonyl carbon by the keto/enol 
tautomerization and (iii) the sequential proton abstraction from the protonated His78 by the C7 
carbonyl oxygen proceed to facilitate the C2-C7 aldol cyclization, with the restoration of His78 (Fig. 
10B, C). Finally, (iv) the enzyme releases the CoA-linked cyclized product, which is immediately 
subjected to aromatization and CoA bond cleavage to form OA, in a non-enzymatic and spontaneous 
manner (Fig.10D, E).  
 Interestingly, despite the lack of OA-forming activity as previously reported, a comparison 
of the crystal structure of OAC with other DABB proteins revealed that the structurally closest, 
functionally uncharacterized AtHS1 conserves the His5/Tyr72/His78/Asp96 arrangement in the 
structure, in a location and orientation very similar to those in OAC (Fig. 5A, B). Most of the other 
residues, including Tyr27 of OAC, are also superimposable in nearly identical positions in AtHS1. The 
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difference between both proteins is only the shape and size of the active-site cavity. This is basically 
due to the distinctive sequence of Leu15, Ala17, Leu31, Phe48, Phe93, Leu94, Leu97, Val100, and 
Val102 in AtHS1 (Fig. 2). Thus, the side-chains of Phe93 and Leu94 in AtHS1 uniquely participate in 
the formation of the hydrophobic tunnel of AtHS1, instead of Phe23 and Trp89 in OAC. The side-
chains of Leu15 and Tyr35 of AtHS1, corresponding to Ile7 and Tyr27 in OAC, also protrude toward 
the tunnel, as compared to those of OAC. Thereby, the hydrophobic pocket of AtHS1 has a different 
shape and size from the active-site cavity of OAC. According to these observations, we propose that 
AtHS1 is another polyketide cyclase that accepts an acyl poly-b-ketide CoA as the substrate to 
generate another plant polyketide, by employing the same reaction mechanism as that of OAC. 
 However, a comparison of the crystal structures of OAC and TcmI indicated that the active-
site architecture of OAC is conformationally different from that of TcmI, although both enzymes share 
the same overall folding and possess the active-site cavity in the interior of the a+b barrel. Notably, 
the Tyr72/His78 arrangement is not conserved in the structure of TcmI (Fig. 5A, C). Furthermore, site-
directed mutagenesis studies of TcmI also suggested that the substitutions of His26, Arg40, and His51, 
located deep inside the active-site cavity, only decrease the Tcm F1-forming activity. These findings 
suggested that TcmI employs a distinct catalytic mechanism from that of OAC for the C9-C10 aldol 
cyclization of Tcm F2, to produce Tcm F1. Gagne and co-workers proposed that OAC and the 
bacterial DABB-type cyclases are an example of convergent evolution, with the polyketide cyclizing 
activity arising independently in plants and bacteria [7]. The crystal structure of OAC also supports 
this hypothesis. 
 In conclusion, our structural and functional analyses revealed the intimate structural details 
of the catalytic mechanism of OAC, for the formation of OA. The mechanism is facilitated by the 
acid/base catalytic chemistry, as suggested in the similar catalytic mechanisms of the structurally and 
functionally distinct bacterial polyketide cyclases, SnoaL and Tcm ARO/CYC [2, 4]. Interestingly, the 
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catalytic Tyr72 and His78 observed in OAC are conserved in homologous proteins widely distributed 
in plants, such as POP3 in Medicago sativa and the POP3-like proteins deposited with unknown 
functions, as in the case of AtHS1. It is thus assumed that the proteins also possess hydrophobic 
tunnels equivalent to the pentyl-binding pocket of OAC, and may function as polyketide cyclases. 
Furthermore, recent studies have suggested that the biosyntheses of plant polyketides, such as the 
anthranoid produced by Aloe arborescens [23, 24], require additional enzymes for the proper folding 
and cyclization of the linear poly-β-keto intermediate to generate the final products, as in the cases of 
cannabinoid and bacterial polyketide biosyntheses. The present results provide insights not only into 
the functional diversity of the DABB family enzymes, but also the structural basis for analyses of 
plant polyketide cyclases that will be discovered in the future. 
 17 
Materials and methods 
Materials 
OA was synthesized from olivetol, as previously reported [25]. OA-NAC was synthesized from OA, 
according to the synthesis of benzoyl-NAC with some modifications [26]. Standard chemicals were 
purchased from Sigma-Aldrich (St. Louis, MO, USA), Wako Pure Chemical Industry (Osaka, Osaka, 
Japan), Hampton Research (Aliso Viejo, CA, USA), and QIAGEN (Germantown MD, USA). The 
pET22b expression plasmid encoding TKS was purchased from Eurofins Genomics (Tokyo, Tokyo, 
Japan). 
 
Expression and purification of Non- and SeMet-labeled wild-type OACs 
The non-labeled recombinant OAC, with a GST-tag at the N-terminus, was overexpressed in 
Escherichia coli M15 and purified, as previously reported [9]. Se-Met labeled OAC was 
overexpressed in E. coli M15, grown in M9 medium containing 1 mM MgSO4, 0.1 mM CaCl2, 1 × 
BME vitamins solution (Sigma-Aldrich), 0.4%(w/v) glucose, and 100 µg/mL ampicillin, at 37 ˚C until 
the OD600 reached 0.6. For the expression of Se-Met labeled OAC, 25 mg/L selenomethionine, 100 
mg/L each of L-Lys, L-Thr, L-Ile, L-Leu, L-Val, and L-Phe, and 1.0 mM isopropyl-b-D-
thiogalactopyranoside (IPTG) were then added, and the cells were cultured further for 24 hours at 17 
˚C. The SeMet-labeled OAC was purified using the same procedure as that for the non-labeled 
recombinant OAC [9]. 
 
Site-directed mutagenesis and purification and crystallization of mutant enzymes 
All of the mutant enzymes were constructed with a QuikChange site-directed mutagenesis kit 
(Stratagene, La Jolla, CA, USA), according to the manufacturer’s protocol. The mutant enzymes were 
expressed, extracted, and purified by the same procedure used for the non-labeled wild-type OAC [9]. 
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Crystallization and structure determination 
All crystallization experiments were performed using the sitting-drop vapor-diffusion technique, with 
incubation at 5 ˚C. Diffraction quality Se-Met labeled and native wild-type OAC apo crystals were 
obtained as previously reported [9]. Crystals of the OAC-OA complex were obtained under conditions 
with 100 mM Tris-HCl (pH 8.8) and 25%(w/v) PEG6000, by co-incubating 25 mg/mL OAC with 50 
mM OA. Diffraction quality crystals of the OAC H5Q, I7F, Y27F, Y27W, V59M, Y72F, and H78S 
mutants were obtained in the optimized reservoir conditions listed in Table 2, after initial screening in 
the same manner as that for the wild-type apo crystals. All crystals were transferred into a 
cryoprotectant solution, consisting of each crystallization solution with 10%(v/v) glycerol. After a few 
seconds, the crystals were picked up in a nylon loop and then flash-cooled at -173 oC in a nitrogen-gas 
stream. Single-wavelength anomalous diffraction (SAD) data of the Se-Met labeled OAC apo crystals 
and diffraction data of the OAC apo, OAC I7F, Y27F, Y27W, V59M, and H78S mutant crystals were 
collected on beamline NW-12A, at the Photon Factory (PF). Diffraction data of the OAC-OA binary 
complex crystals were collected on beamline NE-3A at PF. Diffraction data of the OAC Y72F mutant 
crystals were collected on beamline BL-17A at PF. The 0.97908 Å wavelength at NW12A was used 
for the SAD data collection of the OAC crystals, on the basis of the fluorescence spectrum of the Se K 
absorption edge [27]. Diffraction data of H5Q were collected using in-house X-ray diffraction 
equipment, consisting of a Rigaku MicroMax-7HF high-intensity microfocus rotating anode X-ray 
generator and an R-AXIS VII detector (Rigaku, Akishima, Tokyo, Japan). These diffraction data were 
processed and scaled with the HKL-2000 program package [28] for the OAC I7F mutant enzyme and 
XDS [29] for the other enzymes. 
 The Se sites were determined and refined, and then the initial phase of the Se-Met labeled 
OAC apo structure was calculated with AutoSol [30] in Phenix [31], and the native structure of apo 
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OAC with the highest resolution was determined by the molecular replacement method, using the Se-
Met labeled OAC structure as a search model, with Molrep [32] in the CCP4 suite [33]. The structure 
refinement of apo OAC was performed using Phenix.refine [34] with the twin operator (-h, -k, l) at 
0.08 of twin fractions. The merohedral twin operator of the apo OAC crystals was found, using 
Xtriage [31]. Molecular replacements were performed with the apo OAC structure as the search model, 
using Phaser [35] in the CCP4 suite [33], to solve the structures of the OAC-OA binary complex and 
the OAC H5Q mutant enzyme, and Molrep [32] in the CCP4 suite [33] for the other enzymes. The 
structures were modified manually with Coot [36] and refined with Phenix.refine [34]. The structure 
refinement of the OAC V59M mutant enzyme was performed using Phenix.refine [34] with the twin 
operator (-h, -k, l) at 0.03 of twin fractions, after the merohedral twinning of the mutant enzyme 
crystals was solved using Xtriage [31]. The detailed data collection and refinement statistics are 
summarized in Table 2. The quality of the final models was assessed with Molprobity [37]. The Dali 
program was used for the structure-based similarity search [38]. The active site cavity volume was 
calculated by the CASTp program (http://cast.engr.uic.edu/cast/). All crystallographic figures were 
created with either the CueMol (http://www.cuemol.org) or PyMOL (http://www.pymol.org) program. 
 
Expression and purification of TKS 
The pET22b vector, encoding full-length TKS [20], was transformed into E. coli BL21. The cells 
harboring the plasmid were cultured to an OD600 of 0.6 in LB medium containing 100 µg/mL 
ampicillin, at 37 ˚C. IPTG was added to a final concentration of 0.5 mM to induce protein expression, 
and the culture was incubated for a further 20 h at 20 ˚C. 
 All of the following procedures were performed at 4 oC. The E. coli cells were harvested by 
centrifugation at 6,000 g for 20 min, and then resuspended in 50 mM Tris-HCl buffer (pH 8.0), 
containing 200 mM NaCl and 5% (v/v) glycerol (buffer A). The cells were disrupted by sonication, 
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and the lysate was centrifuged at 8,000 g for 10 min. The supernatant was loaded on a Ni Sepharose 6 
Fast Flow open column (GE Healthcare Life Sciences, Pittsburgh, PA, USA) equilibrated with buffer 
A. After washing with buffer A containing 10 mM imidazole, the recombinant TKS was eluted with 
buffer A containing 600 mM imidazole. The resultant protein solution was concentrated to 5 mL, and 
further purified by gel-filtration chromatography on HiLoad 16/60 Superdex 200 pg (GE Healthcare 
Life Sciences). Finally, the purified enzyme was concentrated to 26 mg/mL in 20 mM HEPES-NaOH 
(pH 7.5) buffer, containing 25 mM NaCl and 5% (v/v) glycerol. 
 
Standard enzyme reaction 
The reaction mixture contained 60 µM of hexanoyl-CoA, 100 µM of malonyl-CoA, 10 µg of the 
purified TKS, and 30 µg of the purified wild-type or mutant OAC enzyme, in a final volume of 500 
µL of 100 mM potassium phosphate buffer (KPB, pH 7.0). The boiled enzymes were used for control 
experiments. The each experiment was performed in triplicate. Incubations were performed at 20 °C 
for 16 h, and were stopped by the addition of 50 µL of 20% HCl. The products were then extracted 
with 3 mL of ethyl acetate, and were analyzed by an online LC-EIS-MS system with an Agilent 
Technologies series 1100 HPLC (Santa Clara, CA, USA) coupled to a Bruker Daltonics esquire 4000 
ion-trap mass spectrometer fitted with an ESI source (Bruker Daltonik GmbH, Bremen, Germany). 
HPLC separations were performed on a TSK-gel ODS-80Ts column (4.6 i.d. ×150 mm, TOSOH, 
Tokyo, Tokyo, Japan), at a flow rate of 0.9 mL⁄ min. Gradient elution was performed with H2O and 
MeOH, both containing 0.1% trifluoroacetic acid: 0–5 min, 30% MeOH; 5–17 min, linear gradient 
from 30 to 60% MeOH; 17–25 min, 60% MeOH; 25–27 min, linear gradient from 60 to 70% MeOH; 
and 27–40 min, linear gradient from 70 to 100% MeOH. Elutions were monitored by a multichannel 
UV detector (MULTI 340, JASCO, Hachioji, Tokyo, Japan), and UV spectra (198–400 nm) were 
recorded every 0.4 s. The ESI capillary temperature and the capillary voltage were 350 °C and 4.0 V, 
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respectively. The tube lens offset was set at 20.0 V. All spectra were obtained in the positive mode 
over a mass range of m⁄z 50–800, and at a range of one scan every 0.2 s. The collision gas was helium, 
and the relative collision energy scale was set at 30.0% (1.5 eV). The peak area data of OA at the 260 
nm on the HPLC elution profile obtained from each enzyme reaction was employed to derive the 
percentages of the OA production relative to that of wild-type OAC (average of triplicates ± SD). 
 
OAC and OA-NAC co-incubation assay 
The assay mixture contained 30 µg OAC and 0.3 nmol OA-NAC, in a final volume of 500 µL of 100 
mM KPB (pH 7.0). The boiled OAC and TKS were used for the control experiments. Incubations were 
performed at 20 °C for 16 h, and were stopped by the addition of 50 µL of 20% (v/v) HCl. The 
products were then extracted with 1 mL of ethyl acetate and were analyzed by an online LC-ESI-MS 
system, using the same ESI-MS method as described above. HPLC separations were performed on a 
TSK-gel ODS-80Ts column (4.6 i.d. ×150 mm, TOSOH), at a flow rate of 0.6 mL⁄ min. Gradient 
elution was performed with 25 mM KPB (pH 6.5) and CH3CN: 0–5 min, 20% CH3CN; 5–17 min, 
linear gradient from 20% to 35% CH3CN; 17–25 min, 35% CH3CN; 25–27 min, linear gradient from 
35% to 40% CH3CN; and 27–40 min, linear gradient from 40% to 70% CH3CN. 
 
Docking model of OAC complexed with the substrate and the cyclized intermediate 
Three-dimensional structures of pentyl-b-ketide- and its cyclized intermediate-CoAs were generated 
by the Chem3D Ultra 10 program (CambridgeSoft, Waltham, MA, USA), and their geometries were 
optimized using elbow in Phenix [31]. The OAC models bound the substrate and cyclized 
intermediate-CoA were manually built by superimposing petnyl and polyketide thioester moieties of 
the substrate and intermediate molecules on the electron-density of the OA molecule in the OAC-OA 
binary complex structure with Coot, respectively. The OAC-substrate and -intermediate binary 
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complex models were then performed energy minimizations by CNS 1.2 [36], and are used for further 
analyses. 
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Figure Legends 
Figure 1. Enzymatic formation of polyketides by polyketide cyclases. (A) Nogalaviketone, (B) Tcm 
F2-ACP, (C) Tcm F1, and (D) OA. 
 
Figure 2. Primary sequence comparison of OAC with other DABB proteins. The secondary structures 
of OAC are delineated as follows: α-helices (green rectangles), β-strands (orange arrows), and loops 
(red, bold lines). The proposed catalytic residues of OAC and the equivalent residues of AtHS1 are 
colored red (numbering according to OAC-OA). Abbreviations (Uniprot codes): Arabidopsis thaliana 
AtHS1 (Q9LUV2), Populus tremula SP1 (P0A881), Arabidopsis thaliana At5g22580 (Q9FK81), 
Streptomyces glaucescens TcmI cyclase (P39890), S. coelicolor ActVA-Orf6 (Q53908), Pseudomonas 
reinekei MLMI (C5MR76), S. nogalater SnoaB (O54259), Mycobacterium tuberculosis Rv0793 
(O86332), P. aeruginosa PA3566 (Q9HY51). 
 
Figure 3. Overall structure of OAC. (A) The apo OAC structure in an asymmetric unit. (B) Structure 
comparisons of monomer A with monomer B. (C) Overall structures of the OAC-OA binary complex 
in an asymmetric unit. (D) The homodimeric structure of OAC, formed by a crystallographic two-fold 
axis. (E) Stereo view of active site cavity of OAC-OA binary complex. (F) Structure comparisons of 
monomer A in OAC apo with the OAC-OA binary complex. Monomers A and B in the OAC apo and 
monomer in the asymmetric unit in the OAC-OA binary complex and its symmetric monomer are 
shown in salmon, sky blue, white, and wheat cartoon models, respectively. His5, Tyr27, Tyr72, His78, 
and Asp96, previously reported mutated residues, and the residues forming the dimer interface are 
depicted by stick models. The previously reported mutated residues are highlighted in red residue 
numbers. The residues forming the dimer interface are labeled with blue residue numbers, and the 
hydrogen bonds are depicted by light blue dashed lines, respectively. The OA molecule bound in the 
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OAC structure is shown by a green stick model. Electron density maps of OA are displayed with blue 
meshes (Fo - Fc > 2.0 s). 
 
Figure 4. Structure comparison of OAC with other plant and bacterial DABB proteins. (A) OAC-OA, 
(B) AtHS1, (C) SP1, (D) At5g22580, (E) SnoaB, (F) Rv0793, (G) MLMI, (H) ActVA-Orf6, (I) 
PA3566, and (J) TcmI. Each main structure is represented by a cartoon model. The proposed catalytic 
residues are depicted by stick models. Olivetolic acid, 3-methylmuconolactone, and acetyl dithranol, 
bound in the OAC, MLMI, and ActVA-Orf6 structures, respectively, are depicted by green stick 
models. 
 
Figure 5. Close-up views of the active-site cavity of OAC, AtHS1, and TcmI. (A) OAC, (B) AtHS1, 
and (C) TcmI. The active-site cavity of OAC is shown in stereo. The OA molecule bound in the OAC 
structure and the hydrogen bonds are depicted by a green stick model and light blue dashed lines, 
respectively. 
 
Figure 6. HPLC elution profiles of enzyme reaction products from hexanoyl-CoA and malonyl-CoA 
with TKS and OAC wild-type or mutant enzymes. 
 
Figure 7. The active-site architectures of wild-type OAC and the OAC mutant enzymes. The active-
site architectures of (A) OAC wild-type, and the OAC mutant enzymes (B) H78S, (C) Y72F, (D) H5Q, 
(E) Y27F, (F) Y27W, (G) I7F, and (H) V59M. The OA molecule bound in the wild-type OAC structure 
is superimposed on the active-site cavity of the mutant enzymes, and depicted by a green stick model. 
The van der Waals force of OA and the hydrogen bonds are depicted by dotted surfaces and light blue 
dashed lines, respectively. 
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Figure 8. HPLC elution profiles of enzyme reaction products obtained by the OAC and OA-NAC co-
incubation assay. Enzyme reaction products of (A) OAC with OA-NAC, (B) TKS with OA-NAC, and 
(C) boiled OAC and TKS with OA-NAC. (D) Authentic OA and OA-NAC. 
 
Figure 9. Stereo views of docking models of OAC. (A) Model structure of OAC bound the pentyl-b-
ketide-CoA molecule and (B) model structure of OAC bound the cyclized intermediate-CoA. The 
pentyl tetra-b-ketide- and its cyclized intermediate-CoA were shown as green stick models. His5, 
Tyr27, Tyr72, His78, Asp96 are depicted by stick models.  
 
Figure 10. Proposed mechanism for the formation of OAC by OA. (A) The proton exchange between 
His78 and Tyr72 and Proton abstraction from His78 at C2 of the substrate. (B and C) The C2-C7 aldol 
cyclization of the intermediate to generate the OAC final product, and the restoration of His78 to its 
initial state in the enzyme reaction. (D and E) Spontaneous aromatization and CoA bond cleavage of 
the CoA-linked cyclized product released by OAC. 
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Table 1. Activities of mutant OAC enzymes relative to the wild-type. 
Enzymes Relative activity* (%) Enzymes Relative activity* (%) 
Wild-type 100 ± 0.03 Y27L 48 ± 0.05 
H5L 36 ± 0.11 Y27M 30 ± 0.07 
H5Q 22 ± 0.81 Y27W 37 ± 0.15 
H5S 47 ± 0.35 V59M 65 ± 0.11 
I7L 85 ± 0.23 Y72F 0 
I7F 64 ± 0.04 H78N 0 
F24L 49 ± 0.22 H78Q 0 
Y27F 162 ± 0.63 H78S 0 
* Activities are percentages of OA production relative to that of wild-type OAC (average of triplicates ± SD).  
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Table 2. Data collection, phasing and refinement statistics 
Sample name                      
(PDB code) 
OAC                                      
(Se-Met) 
OAC                                
(Native, 5B08) 
OAC-OA                         
(5B09) 
Sample conditions    
  Reservoir condition 0.1 M Tris-HCl, pH 8.8 
25% (w/v) PEG6000 
0.1 M Sodium malonate 
0.1 M Tris-HCl, pH 8.8 
25% (w/v) PEG6000 
0.1 M Sodium malonate 
0.1 M Tris-HCl, pH 8.8 
25% (w/v) PEG6000 
50 mM olivetolic acid 
5% (v/v) methanol 
  Cryoprotectanta 10% (v/v) glycerol 10% (v/v) glycerol 10% (v/v) glycerol 
Data collection    
  Beamline PF NW12A PF NW12A PF NE3A 
  Wavelength (Å) 0.97908 1.00000 1.00000 
Space group P3221 P3221 C2 
  a, b, c (Å) 47.7, 47.7, 176.2 47.4, 47.4, 175.9 86.5, 30.5, 36.9 
  α, β, γ (o)   β = 108.5 
  Resolution range (Å) 50.0 - 1.40 (1.49 - 1.40) 50.0 - 1.32 (1.40 - 1.32) 50.0 - 1.70 (1.80 - 1.70) 
  Completeness (%) 99.7 (98.0) 98.6 (93.2) 98.5 (92.3) 
  <I/σ(I)> 19.0 (3.8) 28.0 (11.4) 27.9 (5.1) 
  Rmerge (%)b 6.0 (38.9) 4.9 (16.9) 4.1 (31.0) 
  Multiplicity 5.5 (5.4) 9.9 (9.7) 6.8 (4.7) 
  No. of observed    
  reflections  
484,317 479,942 70,068 
  No. of unique   
  reflections    
87,398 53,774 10,098 
Refinement    
  Resolution (Å)  39.94 -1.32 32.11-1.70 
  Overall Rwork (%)c  19.7 19.7 
  Overall Rfree (%)d  21.5 22.3 
  Chain order in 
  the unit cell 
 A 2 - 101 3 - 50, 54 - 101 
 B -2 - 101  
Total Atoms  1,995 
 
883 
  No. of protein atoms    1,732 811 
  No. of ligand atoms   - 16 
  No. of solvent atoms  223 56 
Average B factors (Å)    
  Protein atoms  8.73 23.5 
  Ligand atoms  - 31.6 
  Solvent atoms  12.48 30.5 
R. m. s. d. from ideal    
  Bond length (Å)  0.007 0.010 
  Bond angles (°)  1.027 1.156 
Ramachandran plot    
  Favored region  98.0% 100% 
  Allowed region  2.0% 0% 
  Outlier region  0% 0% 
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Sample name                    
(PDB code) 
OAC H5Q                         
(5B0A) 
OAC I7F                              
(5B0B) 
OAC Y27F                       
(5B0C) 
Sample conditions    
  Reservoir condition 0.1 M Sodium acetate 
25% (w/v) PEG4000 
8% (v/v) isopropanol 
0.1 M Sodium acetate 
 pH 4.7 
25% (w/v) 
PEG2000MME 
0.1 M Sodium HEPES  
pH 7.5 
25% (w/v) PEG3000 
  Cryoprotectanta 10% (v/v) glycerol 10% (v/v) glycerol 10% (v/v) glycerol 
Data collection    
  Beamline R - AXIS VII PF NW12A PF NW12A 
  Wavelength (Å) 1.54180 1.00000 1.00000 
Space group P21 P21 P21 
  a, b, c (Å) 36.8, 30.5, 81.5 43.4, 45.2, 94.4 85.9, 30.3, 36.7 
  α, β, γ (o) β = 95.5 β = 96.3 β = 108.5 
  Resolution range (Å) 50.0 - 2.10 (2.22 - 2.10) 50.0 - 2.18 (2.26 - 2.18) 50.0 - 1.60 (1.70 - 1.60) 
  Completeness (%) 95.8 (91.2) 99.3 (96.0) 99.3 (98.6) 
  <I/σ(I)> 31.9 (13.0) 21.5 (5.0) 42.3 (13.0) 
  Rmerge (%)b 2.4 (9.9) 7.4 (29.6) 2.0 (8.9) 
  Multiplicity 3.5 (3.3) 3.7 (3.6) 3.6 (3.5) 
  No. of observed  
  reflections  
38,289 70,778 86,682 
  No. of unique   
  reflections    
10,898 19.023 23,862 
Refinement    
  Resolution (Å) 34.65 - 2.10 43.14 - 2.19 34.59 - 1.80 
  Overall Rwork (%)c 22.2 20.1 19.3 
  Overall Rfree (%)d 27.4 25.4 23.0 
  Chain order in 
  the unit cell 
A 2 - 50, 54 - 63, 66 - 101 A - D 2 - 101 A, B 2 - 101 
B 2 - 63, 69 - 101   
Total Atoms 1,655 3,331 1,913 
  No. of protein atoms   1,604 3,144 1,684 
  No. of ligand atoms  - 16 - 
  No. of solvent atoms 51 171 229 
Average B actors (Å)    
  Protein atoms 27.7 25.2 14.8 
  Ligand atoms - 23.4 - 
  Solvent atoms 28.0 31.7 21.7 
R. m. s. d. from ideal    
  Bond length (Å) 0.011 0.010 0.007 
  Bond angles (°) 1.118 1.289 1.149 
Ramachandran plot    
  Favored region 98.9% 99.7% 99.0% 
  Allowed region 1.1% 0.3% 1.0% 
  Outlier region 0% 0% 0% 
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Sample Name          
(PDB code) 
OAC Y27W            
(5B0D) 
OAC V59M         
(5B0E) 
OAC Y72F                                       
(5B0F) 
Sample conditions    
  Reservoir condition 0.1 M MES, pH 6.5 
25% (w/v) PEG3000 
0.1 M Tris-HCl 
pH 8.5 
15% (w/v) PEG20000 
0.3 M tris-Sodium 
citrate 
33% (w/v) PEG6000 
  Cryoprotectanta 10% (v/v) glycerol 10% (v/v) glycerol 10% (v/v) glycerol 
Data collection    
  Beamline PF NW12A PF NW12A PF BL17A 
  Wavelength (Å) 1.00000 1.00000 0.98000 
  Space group P21 P3221 P21 
  a, b, c (Å) 82.1, 29.8, 36.4 47.7, 47.7, 176.9 35.8, 63.6, 46.6 
  α, β, γ (o) β = 96.6  β = 108.3 
  Resolution range (Å) 50.0 - 1.80 
(1.91 - 1.80) 
50.0 - 1.60  
(1.70 - 1.60) 
50.0 - 1.60  
(1.70 - 1.60) 
  Completeness (%) 99.5 (98.8) 99.9 (99.7) 98.0 (96.7) 
  <I/σ(I)> 13.1 (2.4) 26.2 (7.0) 19.1 (3.0) 
  Rmerge (%)b 7.5 (58.7) 7.2 (34.7) 5.6 (59.6) 
  Multiplicity 3.6 (3.5) 10.7 (10.6) 5.7 (5.6) 
  No. of observed   
  reflections 
60.041 339,339 146,242 
  No. of unique   
  reflections 
16,563 31,774 25,752 
Refinement    
  Resolution (Å) 34.58 - 1.80 41.30 - 1.60 44.23 - 1.60 
  Overall Rwork (%)c 19.6 21.2 17.5 
  Overall Rfree (%)d 24.5 23.5 22.3 
  Chain order in       
  the unit cell 
A, B 2 - 101 A 2 - 101 A, B 2 - 101 
 B -2 - 101  
Total Atoms 1,791 1,873 1,826 
  No. of protein atoms   1,672 1,711 1,684 
  No. of ligand atoms  - 6 6 
  No. of solvent atoms 119 156 136 
Average B factors (Å)    
  Protein atoms 24.2 24.1 26.7 
  Ligand atoms - 21.2 23.5 
  Solvent atoms 31.1 26.7 33.5 
R. m. s. d. from ideal    
  Bond length (Å) 0.009 0.009 0.006 
  Bond angles (°) 1.199 1.084 1.005 
Ramachandran plot    
  Favored region 99.0% 98.5% 99.5% 
  Allowed region 1.0 % 1.5% 0.5% 
  Outlier region 0% 0% 0% 
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Sample Name          
(PDB code) 
OAC H78S             
(5B0G) 
Sample conditions  
  Reservoir condition 0.1 M MES pH 6.5 
30% (w/v) PEG4000 
  Cryoprotectanta 10% (v/v) glycerol 
Data collection  
  Beamline PF NW12A 
  Wavelength (Å) 1.00000 
  Space group C2 
  a, b, c (Å) 85.0, 32.7, 36.6 
  α, β, γ (o) β = 108.3 
  Resolution range (Å) 50.0 - 1.40  
(1.48 - 1.40) 
  Completeness (%) 99.2 (98.7) 
  <I/σ(I)> 25.3 (9.1) 
  Rmerge (%)b 3.3 (13.0) 
  Multiplicity 3.6 (3.5) 
  No. of observed   
  reflections 
68,894 
  No. of unique   
  reflections 
18,918 
Refinement  
  Resolution (Å) 40.38 - 1.40 
  Overall Rwork (%)c 17.4 
  Overall Rfree (%)d 20.0 
  Chain order in       
  the unit cell 
2 - 101 
 
Total Atoms 994 
  No. of protein atoms   839 
  No. of ligand atoms  - 
  No. of solvent atoms 155 
Average B factors (Å)  
  Protein atoms 13.4 
  Ligand atoms - 
  Solvent atoms 24.7 
R. m. s. d. from ideal  
  Bond length (Å) 0.009 
  Bond angles (°) 1.215 
Ramachandran plot  
  Favored region 99.0% 
  Allowed region 1.0% 
  Outlier region 0% 
a The cryoprotectant was mixed into each crystallization reservoir. 
b Rmerge =ShSj |<I>h – Ih,j| / ShSjIh,j, where <I>h is the mean intensity of symmetry-equivalent reflections. 
c Rwork = S|Fobs -Fcal| / SFobs, where Fobs and Fcal are observed and calculated structure factor amplitudes.  
d Rfree value was calculated for theR factor, using only an unrefined subset of reflection data. 
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Fig. 1 
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Fig. 4 
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Fig. 5 
 
 41 
Fig. 6 
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Fig. 8 
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